SCHEMBL6948640

SCHEMBL6948640

CCCC1=NN(c2ccc(S(=O)(=O)NC(C)(C)C)cc2)C(=O)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHMT2 P34897 1/20 0.48
ALDH1A1 P00352 10/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
MAPK1 P28482 1/20 0.39
RXFP1 Q9HBX9 1/20 0.37
LOX P28300 1/20 0.36
KDM4E B2RXH2 1/20 0.36
RECQL P46063 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949017 0.81 SHMT2 (0.54) SHMT2ALDH1A1LMNATSHRMAPT
SCHEMBL5976250 0.78 SHMT2 (0.62) SHMT2ALDH1A1LMNATSHRMAPT
SCHEMBL5976498 0.75 SHMT2 (0.59) SHMT2ALDH1A1LMNATSHRMAPT
SCHEMBL5975717 0.75 SHMT2 (0.59) SHMT2ALDH1A1LMNATSHRMAPT
SCHEMBL5975777 0.75 KMT2A (0.60) SHMT2ALDH1A1LMNATSHRMAPT
SCHEMBL4664734 0.75 SHMT2 (0.82) SHMT2ALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL5976511 0.75 SHMT2 (0.55) SHMT2ALDH1A1LMNATSHRMAPT
SCHEMBL14559421 0.74 SHMT2 (0.57) SHMT2ALDH1A1LMNATSHRMAPT
SCHEMBL6949830 0.74 SHMT2 (0.60) SHMT2ALDH1A1LMNATSHRMAPT
SCHEMBL6946002 0.74 MAPT (0.55) SHMT2ALDH1A1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed